Tongue cancer is uncommon but not exceedingly rare. Oral cavity and pharynx cancers together account for about 2.9% of all new cancer cases in the United States, with an estimated 59,660 new diagnoses expected in 2025. That puts it well outside the top ten most common cancers, which are led by breast, prostate, and lung cancers. The overall incidence rate for oral and pharyngeal cancers combined is 11.6 per 100,000 people per year.
Where Tongue Cancer Ranks Among Other Cancers
To put that 2.9% figure in perspective, breast cancer alone accounts for roughly 316,950 new cases per year, and even melanoma of the skin, which ranks tenth, sees about 104,960. Oral and pharyngeal cancers, at roughly 59,660 cases, fall below that threshold. Within this broader category, the tongue is one of the most commonly affected sites alongside the lip and floor of the mouth, but it still represents a small slice of overall cancer diagnoses.
About 90% of tongue cancers are squamous cell carcinomas, meaning they start in the flat cells lining the surface of the tongue. The remaining cases include rare tumor types like minor salivary gland cancers.
Two Types With Different Profiles
Not all tongue cancers are the same. The front two-thirds of the tongue (the part you can see and move) is classified as part of the oral cavity. The back third, called the base of the tongue, is technically part of the throat. This distinction matters because the two types have different risk factors and outcomes.
Base-of-tongue cancers are strongly linked to HPV (human papillomavirus). Roughly 80% of oropharyngeal cancers in the U.S. are HPV-associated, which is a dramatic shift from decades past when nearly all cases were tied to tobacco and alcohol. HPV-related tongue cancers tend to appear in younger patients and often respond better to treatment. Oral tongue cancers, by contrast, are more closely tied to smoking and drinking, though researchers have noted a worrying rise in cases among younger women and people without traditional risk factors.
Who Gets Tongue Cancer
Globally, tongue cancer has historically been more common in men than women, with incidence rates ranging from 0.5 to 21.2 per 100,000 in males compared to 0.5 to 12.0 in females. However, recent studies tracking diagnoses over time have found the gender gap narrowing. One retrospective cohort study found that women made up slightly more than half of diagnosed cases in certain populations, a shift that caught researchers off guard.
Geography plays a significant role in how common this cancer is. The highest rates in the world are found in South-Central Asia and parts of Oceania, with India, Pakistan, and Papua New Guinea topping the list. In India, widespread use of chewing tobacco and betel nut drives mouth and tongue cancer rates far above the global average. Australia has the highest rates of lip cancer specifically, likely due to intense sun exposure. In lower-risk regions, the incidence can be as low as 0.5 per 100,000.
What Raises Your Risk
Tobacco and alcohol are the two dominant risk factors, and their combined effect isn’t just additive. When someone both drinks heavily and smokes, the risk multiplies. One study found that people who did both had a 300-fold higher risk of oral and pharyngeal cancer compared to people who did neither. That’s not a typo. The two substances appear to work together in damaging the cells lining the mouth and throat, making it far easier for cancer to take hold.
HPV infection, particularly type 16, is the other major risk factor, especially for cancers at the base of the tongue. Unlike tobacco-related cases, HPV-driven tongue cancers often appear in people who have never smoked and don’t drink excessively. HPV vaccination, now widely recommended for adolescents, is expected to reduce these cancers over the coming decades.
Telling a Sore From Something Serious
Most people searching about tongue cancer are probably looking at something in their mouth and wondering if it’s worth worrying about. The good news is that common canker sores are far more likely than cancer. Canker sores are typically small (under a millimeter), yellow or white, surrounded by a red border, and smooth in texture. They don’t bleed or discharge fluid, and they heal within a few days to a couple of weeks.
A lesion worth getting checked is one that doesn’t heal. If a sore on your tongue persists beyond two to three weeks, feels different in texture (rough, patchy, or thickened), bleeds without obvious cause, or is accompanied by a lump in your neck, those are signs that something beyond a canker sore may be happening. Early-stage tongue cancer can look deceptively similar to a harmless ulcer, which is exactly why duration is the most reliable distinguishing factor.
Survival Rates by Stage
When tongue cancer is caught early, outcomes are favorable. For localized tongue cancer (meaning it hasn’t spread beyond the tongue itself), the five-year relative survival rate is 88%. Once it has spread to nearby lymph nodes or tissue, that drops to 70%. If it has reached distant parts of the body, the five-year survival rate falls to 39%. These numbers are based on people diagnosed between 2015 and 2021.
The trend line is encouraging. Studies using national cancer databases show that while tongue cancer incidence has been rising, survival rates have also improved significantly over recent decades, likely due to better surgical techniques, more targeted radiation, and growing recognition of HPV-positive cancers as a distinct and more treatable subtype.
Recurrence After Treatment
Even after successful treatment, tongue cancer can come back. In a study of 275 patients with oral squamous cell carcinoma followed for at least five years, about one in three (32.7%) experienced a recurrence. The most common site of recurrence was the neck (lymph node region), followed by the original tumor site. A smaller group had cancer return in both locations. This recurrence risk is why follow-up visits and imaging remain important for years after treatment ends.